Peter Sieling

Title: Innovations of Peter Sieling

Introduction

Peter Sieling is a notable inventor based in Culver City, California. He has made significant contributions to the field of vaccine development, particularly in the area of cellular adjuvants for viral infections. With a total of eight patents to his name, Sieling's work is at the forefront of innovative medical solutions.

Latest Patents

Sieling's latest patents focus on two-component vaccine formulations and methods. These vaccines consist of an adjuvant component and a therapeutic component. The therapeutic component typically includes a recombinant therapeutic virus that encodes a therapeutic antigen. The adjuvant component is derived from a non-host cell or an immune-stimulating portion thereof. Notably, the use of the adjuvant component enhances the uptake of the therapeutic component into immune-competent cells, even in the absence of specific receptors for entry. Additionally, this adjuvant stimulates the expression of the therapeutic antigen, making it a crucial element in vaccine efficacy.

Career Highlights

Throughout his career, Peter Sieling has worked with prominent companies in the biotechnology sector, including NantBio, Inc. and ImmunityBio, Inc. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects that aim to improve public health through innovative vaccine technologies.

Collaborations

Some of Sieling's notable coworkers include Kayvan R. Niazi and Raymond Wong. Their collaborative efforts have contributed to the advancement of vaccine research and development.

Conclusion

Peter Sieling's contributions to the field of vaccine innovation are significant and impactful. His work on cellular adjuvants and therapeutic components showcases his commitment to advancing medical science. Through his patents and collaborations, Sieling continues to play a vital role in the fight against viral infections.